AFFF Firefighting Foam for Law Firms 2026: Case Volume, Economics and Advertising Strategy

AFFF Firefighting Foam: What Plaintiff Firms Need to Know Right Now

AFFF case acquisition for law firms represents one of the highest-value plaintiff dockets available in 2025, with an estimated claimant pool in the hundreds of thousands and per-case values that experienced litigators project in the six- to seven-figure range. The personal injury track in MDL 2873 is actively building toward bellwether trials scheduled through 2025 and 2026, and early verdicts will reset settlement expectations across the board. Firms that establish volume now will be positioned ahead of the filing surge those verdicts are certain to trigger.

The Litigation Landscape and What It Means for Case Value

MDL 2873 sits in the District of South Carolina under Judge Richard Gergel. Current active plaintiff count is 12,000 and growing. The water utility settlements, 3M's $10.3 billion deal in 2023 and DuPont/Chemours/Corteva's $1.18 billion deal the same year, resolved contamination claims brought by public water systems. Personal injury plaintiffs were explicitly excluded from both. That matters because it means the largest defendants are still fully exposed on the injury side, and the litigation machinery is still in motion.

Bellwether personal injury trials are scheduled across 2025 and 2026, covering kidney cancer, testicular cancer, and thyroid disease cases. These are the trials that will set the valuation benchmark the entire MDL has been waiting for. Before the first verdict, case values are somewhat theoretical. After the first verdict, everyone in the MDL, defendants included, has a number to negotiate around. Firms that have signed cases in hand when those verdicts land are positioned to either negotiate from strength or ride the filing surge that almost always follows a plaintiff-favorable result.

The EPA's 2024 maximum contaminant level rule, which set PFOA and PFOS limits at 4 parts per trillion, is the strongest water quality standard the agency has ever issued. That rule does not create personal injury claims on its own, but it strengthens the causation narrative and the damages argument. When plaintiffs' experts stand up in front of a jury in 2025 or 2026 and talk about PFAS bioaccumulation, the EPA's own standard will be in the background reinforcing every word.

The Claimant Pool: Is There Still Volume to Capture?

The addressable population here is large and geographically concentrated in ways that make targeted advertising practical. The primary exposure group is military firefighters and airport firefighting personnel who trained with or regularly handled AFFF over their careers. Military bases are the highest-density exposure locations, and the geographic footprint spans the entire country. Bases like Pease AFB in New Hampshire, Peterson Space Force Base in Colorado, Tyndall AFB in Florida, and Elmendorf AFB in Alaska represent some of the highest-documented contamination sites, but hundreds of bases used AFFF in firefighting training for decades.

Commercial airports add another layer to the addressable pool. AFFF was standard equipment at major airports across the country, and airport fire departments ran regular training exercises using the foam. Personnel from that world are a legitimate secondary acquisition target.

Is the pool saturated? Not by the standards of most mass torts at this stage. The 12,000 filed cases in the MDL sound like a lot until you consider the size of the military firefighter population over the past 40 years, the number of diagnosed kidney and testicular cancer cases in that demographic, and the fact that many of those individuals have not yet connected their diagnosis to their occupational PFAS exposure. Awareness in the general population is still building. The EPA rule in 2024 generated news coverage that pushed PFAS into more households, but conversion from awareness to a signed retainer requires active outreach. Firms willing to advertise are still finding volume.

Thyroid disease cases are a softer category from a damages standpoint and require more careful qualification, but kidney and testicular cancer cases remain the primary campaign track and have the strongest causation support under Bradford Hill criteria.

AFFF Case Acquisition for Law Firms: Advertising Economics

The channel mix for this tort reflects the occupational exposure profile. Facebook and Meta platforms remain the primary paid channel for reaching military veterans and former airport personnel, largely because the demographic targeting tools allow firms to layer military service history, age, and geographic proximity to known bases. Display and programmatic advertising near high-contamination zip codes adds incremental reach. Google search captures demand from individuals who have already started looking, but search volume for AFFF-specific terms is still building as public awareness grows, so paid social is doing most of the heavy lifting on volume.

Cost per lead on AFFF campaigns currently runs in a range that reflects the tort's maturity level. This is not a brand-new tort with sub-$100 leads, and it is not a fully saturated tort where every firm is bidding on the same audiences. Realistically, firms should expect cost per lead in the $200 to $400 range for qualified military or airport personnel with a cancer diagnosis, depending on channel, geography, and creative execution. Cost per signed case varies more widely based on intake speed and qualification rigor, but well-run operations are signing cases in the $2,000 to $4,500 range. Those numbers will move as the bellwether trials approach and more firms enter the market, so current pricing reflects a window that will not stay open indefinitely.

Creative that converts emphasizes the specific occupational exposure, military service or airport firefighting, and the specific cancers, kidney and testicular in particular. Generic PFAS or AFFF creative without occupational framing generates broader but weaker leads that wash out in intake. Specificity at the ad level saves money downstream.

Intake and Qualification: Getting Cases That Stick

The qualification criteria for a retainable AFFF personal injury case are relatively well-defined at this stage. The firm needs documented occupational exposure, meaning military service or airport employment in a firefighting role, a confirmed diagnosis of kidney cancer, testicular cancer, or thyroid disease, and a timeline that connects the exposure period to the diagnosis. Medical records confirming the diagnosis are the anchor document. Service records or employment records establish exposure. Cases that arrive without one of those legs require more investigative work and carry more risk of falling apart before filing.

Intake speed matters here. The individuals most likely to convert are those who have already been diagnosed and are actively thinking about their options. A lead that sits in a queue for 48 hours loses momentum fast. Firms running this tort well have either invested in AI-assisted intake tools that initiate contact and begin pre-qualification within minutes of a form submission, or they have dedicated intake staff handling AFFF leads specifically rather than routing them through a general queue. Both approaches work. The point is that speed-to-contact directly affects signed-case rates, and the math on cost per acquisition gets worse quickly when intake is slow. For firms thinking about AI-assisted intake more broadly, the operational leverage is real. I covered this in depth in "A Lawyer's Guide to AI" because it is one of the highest-ROI applications plaintiff firms can implement without overhauling their entire operation.

Retainer flow should be digital, fast, and mobile-friendly. The demographic here includes veterans in their 50s and 60s who are entirely comfortable with DocuSign-style e-signature but will not jump through multiple hoops to return a paper retainer. Simplify the retainer package, make it signable on a phone, and follow up by text and email within the same day.

How MTAA Approaches AFFF Campaigns

We have been running AFFF campaigns for plaintiff firms as this tort has developed, and the occupational targeting piece is where a lot of firms either get it right or bleed budget unnecessarily. At MTAA, we manage campaigns on a transparent cost-plus model: firms pay actual ad spend plus a 15% management fee. No hidden markups on media, no blended pricing that obscures where the money is going. That structure matters in a tort like AFFF where the acquisition math is tight enough that cost efficiency at the media level has a real effect on per-case economics.

With $250 million-plus in Facebook ad spend managed across 600-plus plaintiff firms and more than 100 torts, we have the data on what creative angles convert, which audiences exhaust quickly, and how to pace spend relative to MDL timing so firms are not overpaying for leads in a cooling period. AFFF is an active campaign right now. If you are evaluating whether the economics make sense for your firm, the honest answer is that the current window is favorable and it will tighten as bellwether verdicts approach.

The Bottom Line on AFFF Case Acquisition for Law Firms

The personal injury track in AFFF litigation has a clear runway: active MDL, 12,000 and growing plaintiffs, bellwether trials coming in 2025 and 2026, and defendants who still have full personal injury exposure despite writing billion-dollar checks to settle water utility claims. The claimant pool has not been picked over the way later-stage torts typically are. Advertising economics are workable. And the first bellwether verdicts will change the calculus for everyone. AFFF case acquisition for law firms right now is a matter of deciding whether to get positioned before those verdicts land or after. Firms that move early on well-run campaigns will have inventory when settlement discussions accelerate. Firms that wait will be paying more for the same cases. The question is straightforward. The timing is the variable.